19
Participants
Start Date
February 29, 2004
Primary Completion Date
August 31, 2006
Study Completion Date
March 31, 2008
Infliximab
"A total of 6 doses of Infliximab will be administered as follows:~Dose 1: 10 mg/kg IV one day prior to commencing the myeloablative preparative regimen Dose 2: 10 mg/kg IV on day 0 to be given after peripheral blood stem cell infusion Dose 3: 10 mg/kg IV on day +7 Dose 4: 10 mg/kg IV on day +14 Dose 5: 10 mg/kg IV on day +28 Dose 6: 10 mg/kg IV on day +42"
Ohio State University, Columbus
Ohio State University Comprehensive Cancer Center
OTHER